Author's Posts

Emma Day

In Memory of Dr. Gwendolyn Poles-Corker

  • April 24, 2025
  • Emma Day

With great sadness, SCDAA shares the news of the loss of Dr. Gwendolyn Poles-Corker on April 8, 2025. The 71-year-old was... Continue Reading

SCDAA names events manager

  • April 24, 2025
  • Emma Day

The Sickle Cell Disease Association of America Inc., a national nonprofit membership organization that advocates for people affected by sickle cell... Continue Reading

Advocacy Alert: Save the Sickle Cell Data Collection Program

  • April 9, 2025
  • Emma Day

Last week, the Trump administration announced drastic changes and reductions to federal health programs that support the sickle cell disease community.... Continue Reading

SCDAA Statement on the Measles Outbreak

  • March 20, 2025
  • Emma Day

SCDAA is aware of and monitoring the measles outbreaks that have been reported in several states. There is a fair amount... Continue Reading

Black History Month: Our Current Member Organizations

  • February 27, 2025
  • Emma Day

As Black History Month ends, we would like to look to the future for our final #SCDHistoryHighlight at the amazing work... Continue Reading

Black History Month: National Sickle Cell Anemia Control Act

  • February 20, 2025
  • Emma Day

After our founding, one of SCDAA’s earliest goals was to ensure the National Sickle Cell Anemia Control Act of 1972 was... Continue Reading

Black History Month: Our Early Member Organizations

  • February 14, 2025
  • Emma Day

Last week, we learned about the origins of the Sickle Cell Disease Association of America, Inc. (SCDAA) and the vision for... Continue Reading

Black History Month 2025: Dr. Charles F. Whitten

  • February 7, 2025
  • Emma Day

Our first #SCDHistoryHighlight for Black History Month brings attention to the life and work of SCDAA co-founder Dr. Charles F. Whitten. Dr.... Continue Reading

MARAC Statement: ASH Report on Exercise and SCT Crisis Risk

  • February 6, 2025
  • Emma Day

Feb. 5, 2025 – On January 30, 2025, the American Society of Hematology (ASH) published a report that found no evidence... Continue Reading

Editas Medicine Announces Strategic Transition

  • January 24, 2025
  • Emma Day

Editas Medicine recently announced that they will be making a strategic transition to a in vivo gene editing company. The company... Continue Reading